Author

Sandra Muñoz-Galvan

Instituto de biomedicina de Sevilla, IBIS - Cited by 1,039 - gen

Biography

Sandra Muñoz-Galvan, Instituto de Biomedicina de Sevilla (IBiS), HUVR/CSIC/Universidad de Sevilla, Sevilla, Spain. Currently working in Instituto de Biomedicina de Sevilla (IBiS), HUVR/CSIC/Universidad de Sevilla, Sevilla, Spain.  is serving as an editorial member and reviewer of several international reputed journals.  has successfully completed his Administrative responsibilities.    has authored of many research articles/books related to Medicine.
Title
Cited by
Year
NAMPT Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP
A Lucena-Cacace, D Otero-Albiol, MP Jiménez-García, S Muñoz-Galvan, ...Clinical Cancer Research 24 (5), 1202-1215, 2018201
106
2018
Histone H3K56 acetylation, Rad52, and non-DNA repair factors control double-strand break repair choice with the sister chromatid
S Munoz-Galvan, S Jimeno, R Rothstein, A AguileraPLoS genetics 9 (1), e1003237, 2013201
97
2013
Distinct roles of Mus81, Yen1, Slx1-Slx4, and Rad1 nucleases in the repair of replication-born double-strand breaks by sister chromatid exchange
S Muñoz-Galván, C Tous, MG Blanco, EK Schwartz, KT Ehmsen, SC West, ...Molecular and cellular biology 32 (9), 1592-1603, 2012201
77
2012
Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
M Perez, S Muñoz-Galván, MP Jiménez-García, JJ Marín, A CarneroOncotarget 6 (38), 40557, 2015201
62
2015
Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
S Muñoz-Galván, B Felipe-Abrio, EM Verdugo-Sivianes, M Perez, ...Molecular cancer 19 (1), 1-16, 2020202
54
2020
The essential role of PIM kinases in sarcoma growth and bone invasion
M Narlik-Grassow, C Blanco-Aparicio, Y Cecilia, S Peregrina, ...Carcinogenesis 33 (8), 1479-16, 2012201
48
2012
Targeting cancer stem cells to overcome therapy resistance in ovarian cancer
S Muñoz-Galván, A CarneroCells 9 (6), 1402, 2020202
36
2020
Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors
I Ferrer, EM Verdugo-Sivianes, MA Castilla, R Melendez, JJ Marin, ...Oncogene (21), 2777-2788, 2016201
35
2016
Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment
S Muñoz-Galván, A Lucena-Cacace, M Perez, D Otero-Albiol, ...Oncogene 38 (8), 1309-1323, 2019201
35
2019
Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia
M Narlik-Grassow, C Blanco-Aparicio, Y Cecilia, M Perez, ...PloS one 8 (4), e60277, 2013201
33
2013
Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia
M Narlik-Grassow, C Blanco-Aparicio, Y Cecilia, M Perez, ...PloS one 8 (4), e60277, 2013201
33
2013
MAP17 (PDZKIP1) expression determines sensitivity to the proteasomal inhibitor bortezomib by preventing cytoprotective autophagy and NFκB activation in breast cancer
S Muñoz-Galván, G Gutierrez, M Perez, A CarneroMolecular cancer therapeutics 14 (6), 1454-1465, 2015201
30
2015
MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer
MJ de Miguel-Luken, M Chaves-Conde, V de Miguel-Luken, ...Oncotarget 6 (14), 12625, 2015201
29
2015
p38α limits the contribution of MAP17 to cancer progression in breast tumors
MV Guijarro, M Vergel, JJ Marin, S Munoz-Galvan, I Ferrer, S Cajal, ...Oncogene 31 (41), 4447-4459, 2012201
29
2012
New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools
S Muñoz-Galván, B Felipe-Abrio, M García-Carrasco, J Domínguez-Piñol, ...Journal of Experimental & Clinical Cancer Research 38 (1), 1-14, 2019201
27
2019
Competing roles of DNA end resection and non-homologous end joining functions in the repair of replication-born double-strand breaks by sister-chromatid recombination
S Munoz-Galvan, A Lopez-Saavedra, SP Jackson, P Huertas, ...Nucleic acids research 41 (3), 1669-1683, 2013201
26
2013
Oxidation of anticancer Pt (II) complexes with monodentate phosphane ligands: towards stable but active Pt (IV) prodrugs
MÁ Medrano, A Álvarez-Valdés, J Perles, J Lloret-Fillol, S Muñoz-Galván, ...Chemical Communications 49 (42), 4806-4808, 2013201
23
2013
PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome
P Estevez-Garcia, A Castaño, AC Martin, F Lopez-Rios, J Iglesias, ...BMC cancer 12 (1), 1-10, 2012201
23
2012
A new role for Rrm3 in repair of replication-born DNA breakage by sister chromatid recombination
S Muñoz-Galván, M García-Rubio, P Ortega, JF Ruiz, S Jimeno, B Pardo, ...PLoS genetics 13 (5), e1006781, 2017201
22
2017
Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma
P Estevez-Garcia, I Lopez-Calderero, S Molina-Pinelo, S Munoz-Galvan, ...Clinical Cancer Research 19 (14), 3925-3935, 2013201
21
2013

Referred From: https://scholar.google.es/citations?user=oPJEBRIAAAAJ&hl=es

Cited by
Citations 1039
h-index 20
i10-index 26
Recommended Journals
Open Access Journals